Invesco Biotechnology & Genome ETF (PBE) Holdings List

$96.27 -1.40 (-1.43%)

Closing price 09/23/2026 04:10 PM Eastern

Extended Trading

$96.20 -0.07 (-0.07%)

As of 04:01 AM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include Illumina, Natera, and Gilead Sciences. The top 25 PBE holdings ordered by weight make up 87.80% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	ILMN Illumina	$255.38 +3.2%	5.62%	95,636
2	NTRA Natera	$390.79 0.0%	5.61%	63,897
3	GILD Gilead Sciences	$151.37 -0.9%	5.23%	144,633
4	BIIB Biogen	$227.53 +1.0%	5.12%	97,463
5	RPRX Royalty Pharma	$57.65 -1.5%	4.89%	346,648
6	REGN Regeneron Pharmaceuticals	$801.82 -0.3%	4.88%	25,818
7	VRTX Vertex Pharmaceuticals	$516.34 +0.3%	4.82%	38,921
8	AMGN Amgen	$406.09 -1.0%	4.43%	48,651
9	SRPT Sarepta Therapeutics	$18.95 -8.9%	3.07%	620,303
10	NVAX Novavax	$10.55 -2.6%	2.98%	1,243,231
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	EXEL Exelixis	$56.73 -2.4%	2.90%	206,910
12	TGTX TG Therapeutics	$56.00 -3.6%	2.87%	211,761
13	QGEN Qiagen	$43.76 +0.2%	2.86%	268,866
14	HALO Halozyme Therapeutics	$112.44 -2.3%	2.82%	107,360
15	MRNA Moderna	$182.11 -0.2%	2.80%	73,884
16	NBIX Neurocrine Biosciences	$139.49 -1.9%	2.78%	76,529
17	BMRN BioMarin Pharmaceutical	$62.21 -1.8%	2.77%	177,491
18	INCY Incyte	$124.64 -1.8%	2.77%	90,477
19	RGEN Repligen	$184.53 -1.2%	2.76%	64,594
20	UTHR United Therapeutics	$489.42 -1.6%	2.70%	22,631
21	PTGX Protagonist Therapeutics	$138.70 -4.4%	2.68%	77,937
22	ANAB AnaptysBio	$50.77 -5.8%	2.65%	201,066
23	VCEL Vericel	$38.79 -3.6%	2.60%	271,539
24	PTCT PTC Therapeutics	$62.34 -5.5%	2.60%	159,733
25	VCYT Veracyte	$43.82 +1.1%	2.59%	266,490

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 97.2%, followed by Netherlands at 2.8%.

United States
97.2%
Netherlands
2.8%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
94.8%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 97.2%.

Health Care
97.2%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 80.6%, followed by Health Care Equipment & Supplies at 10.8%.

Biotechnology
80.6%
Health Care Equipment & Supplies
10.8%
Health Care Providers & Services
5.9%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 80.6%, followed by Life Sciences Tools & Services at 10.8%.

Biotechnology
80.6%
Life Sciences Tools & Services
10.8%
Health Care Services
5.9%

Related Companies and Tools

Related Companies

MarketBeat tracks Invesco Biotechnology & Genome ETF holdings and portfolio composition, last updated on 9/20/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List